(Q34504490)

2 August 2017

title

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria (English)

1 reference

2 August 2017

C Zoccali

5

0 references

Giuseppe Remuzzi

object named as

G Remuzzi

9

0 references

Piero Ruggenenti

1

object named as

P Ruggenenti

1 reference

2 August 2017

2

A Perna

1 reference

2 August 2017

G Gherardi

3

1 reference

2 August 2017

G Garini

4

1 reference

2 August 2017

M Salvadori

6

1 reference

2 August 2017

F Scolari

7

1 reference

2 August 2017

F P Schena

8

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

2 August 2017

1 reference

2 August 2017

volume

354

1 reference

2 August 2017

issue

9176

1 reference

2 August 2017

page(s)

359-364

1 reference

Understanding the nature of renal disease progression

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910363-X

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910363-X

7 January 2021

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910363-X

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910363-X

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910363-X

7 January 2021

Repeated assessment of results in clinical trials of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910363-X

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910363-X

7 January 2021

Pathophysiology of Progressive Nephropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910363-X

7 January 2021

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2910363-X

7 January 2021

10.1016/S0140-6736(98)10363-X

Identifiers

DOI

1 reference

2 August 2017

1 reference